RaySearch Laboratories AB (publ) (FRA:27R)

Germany flag Germany · Delayed Price · Currency is EUR
26.70
+0.65 (2.50%)
Last updated: Aug 11, 2025
2.50%
Market Cap843.80M
Revenue (ttm)112.16M
Net Income (ttm)17.28M
Shares Outn/a
EPS (ttm)0.50
PE Ratio48.84
Forward PE39.12
Dividend0.28 (1.04%)
Ex-Dividend DateMay 23, 2025
Volumen/a
Average Volume32
Open26.65
Previous Close26.05
Day's Range26.65 - 26.70
52-Week Range11.18 - 32.70
Betan/a
RSI23.26
Earnings DateAug 8, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation... [Read more]

Industry Prepackaged Software
Founded 2000
Employees 416
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 27R
Full Company Profile

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.